Option Care Health Inc

Option Care Health’s insider buying signals long‑term confidence, revealing a steady accumulation of shares amid a solid valuation and growing home‑care market potential.

Insider activity shows a cautious buy by Smyser Collin: 812 shares, no cash, at $22.23—while execs pile in tens of thousands, giving a modest bullish hint for Option Care Health.

Option Care Health insider buying shows confidence: executives acquire 450,000+ shares, under‑priced P/E 16.5, and a strategic focus on high‑margin infusion and home‑care—an attractive value play for healthcare investors.

Option Care Health insiders buy shares at market‑price, hinting confidence amid falling stock; steady long‑term purchases may signal a bullish outlook.

Option Care Health CFO and CEO insider buying signals confidence amid a volatile healthcare sector, hinting at future value‑based contracts and telehealth growth.

Insider selling spurs caution: Option Care Health’s COO sells 4,605 shares amid a 10‑week slump, hinting at looming valuation concerns and a shift in exec confidence.